Stimcell Energetics 

$0.3320
0
-$0.02-5.14% Friday 16:23

Statistics

Day High
0.348
Day Low
0.348
52W High
0.48
52W Low
0.25
Volume
4,500
Avg. Volume
817
Mkt Cap
6.94M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JulExpected
Q1 2026
Next
-0.01
-0.01
-0
0
Expected EPS
-0.01
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-1.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STME. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap27.96B
Dexcom, Inc. specializes in glucose monitoring systems, competing in the medical device sector focused on diabetes management, similar to Cell MedX's focus.
Tandem Diabetes Care
TNDM
Mkt Cap1.05B
Tandem Diabetes Care, Inc. provides innovative insulin delivery systems, directly competing in the diabetes care market where Cell MedX operates.
Insulet
PODD
Mkt Cap10.1B
Insulet Corporation manufactures insulin pump technology, aligning with diabetes management solutions, a field relevant to Cell MedX's interests.
Abbott Laboratories
ABT
Mkt Cap153.99B
Abbott Laboratories offers a broad range of medical devices including glucose monitoring systems, competing in the same healthcare segment as Cell MedX.
Medtronic
MDT
Mkt Cap101.56B
Medtronic plc provides medical technologies, services, and solutions including diabetes management products, directly competing with Cell MedX's offerings.
Senseonics
SENS
Mkt Cap351.85M
Senseonics Holdings, Inc. focuses on the development of glucose monitoring systems, which is a direct competition to Cell MedX's diabetes-related technologies.
Novo Nordisk
NVO
Mkt Cap191.24B
Novo Nordisk A/S, a global healthcare company, focuses on diabetes care products, competing in the same therapeutic area as Cell MedX.
Sanofi
SNY
Mkt Cap101.45B
Sanofi S.A. engages in the development and marketing of therapeutic solutions including diabetes care, which competes with Cell MedX's market.
Merck
MRK
Mkt Cap281.24B
Merck & Co., Inc. provides healthcare solutions including diabetes management drugs and therapies, competing in the broader diabetes care market relevant to Cell MedX.

About

StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Show more...
CEO
Mr. David M. Jeffs
Employees
1
Country
United States
ISIN
US15115X2062

Listings

0 Comments

Share your thoughts

FAQ

What is Stimcell Energetics stock price today?
The current price of STME is $0.33 USD — it has decreased by -5.14% in the past 24 hours. Watch Stimcell Energetics stock price performance more closely on the chart.
What is Stimcell Energetics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Stimcell Energetics stocks are traded under the ticker STME.
Is Stimcell Energetics stock price growing?
STME stock has fallen by -5.14% compared to the previous week, the month change is a -4.84% fall, over the last year Stimcell Energetics has showed a +32.8% increase.
What is Stimcell Energetics market cap?
Today Stimcell Energetics has the market capitalization of 6.94M
When is the next Stimcell Energetics earnings date?
Stimcell Energetics is going to release the next earnings report on July 29, 2026.
What were Stimcell Energetics earnings last quarter?
STME earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Stimcell Energetics revenue for the last year?
Stimcell Energetics revenue for the last year amounts to 0 USD.
What is Stimcell Energetics net income for the last year?
STME net income for the last year is -1.13M USD.
How many employees does Stimcell Energetics have?
As of June 29, 2026, the company has 1 employees.
In which sector is Stimcell Energetics located?
Stimcell Energetics operates in the Other sector.
When did Stimcell Energetics complete a stock split?
The last stock split for Stimcell Energetics was on November 05, 2024 with a ratio of 1:15.
Where is Stimcell Energetics headquartered?
Stimcell Energetics is headquartered in Vancouver, United States.